home / stock / myok / myok short
Short Information | MyoKardia Inc. (NASDAQ:MYOK)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,004,678 |
Total Actual Volume | 21,733,920 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 50,234 |
Average Short Percentage | 5.13% |
Is there a MYOK Short Squeeze or Breakout about to happen?
See the MYOK Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
11-16-2020 | $224.82 | $224.91 | $225 | $224.52 | 2,741,364 | 35,656 | 1.3% |
11-13-2020 | $224.7 | $224.8 | $224.85 | $224.7 | 1,244,191 | 31,492 | 2.53% |
11-12-2020 | $224.43 | $224.74 | $224.84 | $224.43 | 1,350,528 | 180,257 | 13.35% |
11-11-2020 | $224.48 | $224.41 | $224.53 | $224.23 | 2,022,640 | 74,226 | 3.67% |
11-10-2020 | $224.45 | $224.55 | $224.57 | $224.35 | 939,058 | 61,008 | 6.5% |
11-09-2020 | $224.58 | $224.41 | $224.58 | $224.165 | 1,452,938 | 54,893 | 3.78% |
11-06-2020 | $224.49 | $224.41 | $224.57 | $224.4 | 1,202,776 | 40,782 | 3.39% |
11-05-2020 | $224.45 | $224.4 | $224.63 | $224.4 | 646,503 | 15,545 | 2.4% |
11-04-2020 | $224.32 | $224.56 | $224.61 | $224.3 | 1,532,659 | 30,512 | 1.99% |
11-03-2020 | $223.35 | $223.49 | $223.595 | $223.15 | 1,108,872 | 36,463 | 3.29% |
11-02-2020 | $223.36 | $223.28 | $223.425 | $223.09 | 1,074,203 | 45,309 | 4.22% |
10-30-2020 | $223.04 | $223.53 | $223.55 | $222.985 | 686,518 | 55,934 | 8.15% |
10-29-2020 | $223 | $223.32 | $223.49 | $222.8 | 608,035 | 47,087 | 7.74% |
10-28-2020 | $222.81 | $222.805 | $223.135 | $222.685 | 814,745 | 33,698 | 4.14% |
10-27-2020 | $223.25 | $222.91 | $223.25 | $222.81 | 426,506 | 22,778 | 5.34% |
10-26-2020 | $222.54 | $223 | $223 | $222.5 | 437,100 | 21,184 | 4.85% |
10-23-2020 | $222.25 | $222.97 | $222.98 | $222.25 | 540,207 | 40,158 | 7.43% |
10-22-2020 | $222.66 | $222.14 | $222.845 | $222.1 | 1,253,430 | 88,427 | 7.05% |
10-21-2020 | $222.7 | $222.4 | $222.8394 | $222.4 | 1,002,425 | 42,011 | 4.19% |
10-20-2020 | $222 | $222.45 | $222.68 | $221.9 | 649,222 | 47,258 | 7.28% |
News, Short Squeeze, Breakout and More Instantly...
EXPLORER -HCM Cardiac Imaging Data Presented at AHA 2020 Scientific Session with Simultaneous Publication in Circulation Mavacamten T reatment Resulted in Favorable Effect on Cardiac Structure -- Significantly Reduced Hypertrophy in Patien...
ECHO Data from EXPLORER-HCM Show Mavacamten Treatment Improved Cardiac Structure and Mitral Valve Function in Obstructive Hypertrophic Cardiomyopathy Patients Markers of Physical Activity from MAVERICK-HCM Accelerometry Data Correlated with ...
BRISBANE, Calif. and WASHINGTON, Nov. 11, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (NASDAQ: MYOK), and the American College of Cardiology (ACC) announced the establishment of a nationwide registry of hypertrophic cardiomyopathy (HCM), which leverages the ACC’s PINNACLE Cardiovas...